Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Pregnyl Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The historical growth can be ascribed to the increasing utilization of HCG in fertility treatments, the expansion of IVF and ART clinics, its established position in addressing male hypogonadism, the development of greater clinical expertise in hormone therapy, and the availability of injectable fertility drugs.
The anticipated growth during the forecast period is fueled by the increasing incidence of infertility, a heightened need for reproductive assistance, broader availability of fertility treatments, increased understanding of male fertility issues, and the greater acceptance of tailored hormone protocols.
A significant trend during the forecast period is the growing requirement for fertility hormone treatments, coupled with their expanding application in assisted reproductive technologies, a heightened emphasis on therapeutic approaches for male infertility, the wider deployment of injectable hormone solutions, and a greater concentration on regulated hormone delivery methods.
Get A Free Sample Report With In-Depth Market Insights:
Pregnyl Market Growth Catalysts And Demand Drivers
The anticipated expansion of healthcare infrastructure is set to boost the growth of the pregnyl market in the foreseeable future. Healthcare infrastructure encompasses the physical and organizational frameworks, facilities, resources, and systems essential for providing health services to a population. This expansion is propelled by critical elements such as the aging global demographic, a rise in chronic illnesses, and advancements in technology. A robust healthcare infrastructure facilitates pregnyl’s market expansion by guaranteeing accessibility to fertility treatments, appropriate storage, administration facilities, and skilled healthcare personnel. For example, data from the American Hospital Association, a US-based professional organizations company, revealed that as of January 2024, the United States contained 6,120 hospitals, offering a total of 916,752 staffed beds and processing 33,679,935 total admissions across all its facilities in 2024. Additionally, a report released by the Office for National Statistics, a UK-based government agency, in May 2024 indicated that overall healthcare spending saw a 5.6% nominal increase from 2022 to 2023, which contrasts with a 0.9% growth rate recorded in 2022. Consequently, the development of healthcare infrastructure is a significant impetus behind the expansion of the pregnyl market.
Pregnyl Market Breakdown By Product Type And Application
The pregnyl market covered in this report is segmented –
1) By Indication: Fertility Treatments In Women, Male Infertility, Hypogonadotropic Hypogonadism
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End-User: Fertility Clinics, Research Institutions, Other End-Users
Pregnyl Market Trends Shaping Long-Term Demand
In July 2025, Organon & Co., a pharmaceutical company situated in the U.S., finalized the acquisition of Merck & Co., Inc.’s biotech manufacturing facility located at De Geer in Oss; the financial terms of this transaction were not revealed. The primary objective behind this purchase was for Organon to enhance its production capacity for fertility medications and to guarantee a consistent supply of active components for its fertility product range, which includes hCG-based items such as Pregnyl. Merck & Co., Inc. operates as a Germany-based pharmaceutical enterprise, concentrating on pioneering medicines, vaccines, and healthcare remedies across significant therapeutic fields.
Pregnyl Market Company Landscape And Competitive Strategy
Major companies operating in the pregnyl market are Merck & Co.Inc.
View The Full Pregnyl Market Report:
Pregnyl Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the pregnyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
